Pharma Blog Watch

Sharing Clinical Trial Data (QDIS Blog)
"It used to be that major pharma companies did not want to share safety data from clinical trials because they considered the information proprietary," Ed Vawter writes in this blog entry, adding, "There has been much talk recently about changing that."

"Some companies have said they will start their own databases, however, having many different databases with differing information I don't feel would be productive. I also don't think a voluntary program run by a pharma group would be the best solution either."

He concludes that "it will take action from Congress before anything concrete will happen."